UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - NYSE:UHS - US9139031002 - Common Stock
224.505 USD
+1.87 (+0.84%)
Overall UHS gets a fundamental rating of 6 out of 10. We evaluated UHS against 100 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
UHS had positive earnings in the past year.
In the past year UHS had a positive cash flow from operations.
Each year in the past 5 years UHS has been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 8.96%, UHS belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
The Return On Equity of UHS (19.18%) is better than 86.00% of its industry peers.
UHS's Return On Invested Capital of 12.33% is amongst the best of the industry. UHS outperforms 87.00% of its industry peers.
UHS had an Average Return On Invested Capital over the past 3 years of 8.28%. This is in line with the industry average of 9.45%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(12.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROIC | 12.33% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
UHS has a Profit Margin of 8.09%. This is amongst the best in the industry. UHS outperforms 88.00% of its industry peers.
UHS's Profit Margin has been stable in the last couple of years.
UHS has a Operating Margin of 11.47%. This is in the better half of the industry: UHS outperforms 80.00% of its industry peers.
UHS's Operating Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UHS has less shares outstanding than it did 1 year ago.
UHS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, UHS has an improved debt to assets ratio.
2.2 Solvency
UHS has a debt to FCF ratio of 4.84. This is a neutral value as UHS would need 4.84 years to pay back of all of its debts.
UHS has a better Debt to FCF ratio (4.84) than 67.00% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio (0.55) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | N/A |
ROIC/WACC1.45
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.03 indicates that UHS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.03, UHS is not doing good in the industry: 72.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.96 indicates that UHS may have some problems paying its short term obligations.
UHS has a worse Quick ratio (0.96) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.07% over the past year.
The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.21%.
The Revenue has been growing slightly by 6.82% on average over the past years.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.53% yearly.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.90% yearly.
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.79, the valuation of UHS can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 89.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.28. UHS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 9.63, which indicates a very decent valuation of UHS.
91.00% of the companies in the same industry are more expensive than UHS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of UHS to the average of the S&P500 Index (33.61), we can say UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.79 | ||
| Fwd PE | 9.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 82.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UHS is valued a bit cheaper than 77.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.76 | ||
| EV/EBITDA | 7.35 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UHS has a very decent profitability rating, which may justify a higher PE ratio.
UHS's earnings are expected to grow with 15.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)1
EPS Next 2Y18.34%
EPS Next 3Y15.88%
5. Dividend
5.1 Amount
With a yearly dividend of 0.35%, UHS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.55, UHS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, UHS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
5.2 History
The dividend of UHS is nicely growing with an annual growth rate of 6.27%!
UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
3.78% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP3.78%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
NYSE:UHS (11/11/2025, 10:24:41 AM)
224.505
+1.87 (+0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.12%
Inst Owner Change0.53%
Ins Owners5.45%
Ins Owner Change16.82%
Market Cap14.29B
Revenue(TTM)16.99B
Net Income(TTM)1.38B
Analysts70.77
Price Target231.73 (3.22%)
Short Float %3.52%
Short Ratio2.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.35% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP3.78%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.07%
Min EPS beat(2)7.62%
Max EPS beat(2)16.52%
EPS beat(4)4
Avg EPS beat(4)12.73%
Min EPS beat(4)7.62%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)13.14%
EPS beat(12)12
Avg EPS beat(12)10.1%
EPS beat(16)14
Avg EPS beat(16)6.62%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.18%
Max Revenue beat(2)2.44%
Revenue beat(4)3
Avg Revenue beat(4)0.48%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)7
Avg Revenue beat(8)0.45%
Revenue beat(12)9
Avg Revenue beat(12)0.29%
Revenue beat(16)13
Avg Revenue beat(16)0.58%
PT rev (1m)4.41%
PT rev (3m)2.74%
EPS NQ rev (1m)4.75%
EPS NQ rev (3m)5.66%
EPS NY rev (1m)3.24%
EPS NY rev (3m)7.7%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)0.4%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.79 | ||
| Fwd PE | 9.63 | ||
| P/S | 0.84 | ||
| P/FCF | 14.76 | ||
| P/OCF | 7.33 | ||
| P/B | 1.99 | ||
| P/tB | 4.49 | ||
| EV/EBITDA | 7.35 |
EPS(TTM)20.8
EY9.26%
EPS(NY)23.3
Fwd EY10.38%
FCF(TTM)15.21
FCFY6.78%
OCF(TTM)30.61
OCFY13.64%
SpS267.01
BVpS112.66
TBVpS49.97
PEG (NY)0.38
PEG (5Y)1
Graham Number229.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.96% | ||
| ROE | 19.18% | ||
| ROCE | 16% | ||
| ROIC | 12.33% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 18.59% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.09% | ||
| GM | N/A | ||
| FCFM | 5.7% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 162.72% | ||
| Cap/Sales | 5.77% | ||
| Interest Coverage | 15.36 | ||
| Cash Conversion | 76.35% | ||
| Profit Quality | 70.41% | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | N/A |
F-Score8
WACC8.49%
ROIC/WACC1.45
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y28.65%
EPS Next 2Y18.34%
EPS Next 3Y15.88%
EPS Next 5Y13.53%
Revenue 1Y (TTM)10.21%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year10.04%
Revenue Next 2Y7.46%
Revenue Next 3Y6.7%
Revenue Next 5Y4.9%
EBIT growth 1Y26.53%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y135.27%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y75.09%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
What is the valuation status for UHS stock?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for UHS stock?
The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 10.79 and the Price/Book (PB) ratio is 1.99.
Can you provide the financial health for UHS stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 4 / 10.